Alison Langley
Impact in
- Neurology top 1%
- Neuroblastoma Research and Treatments
- Epidemiology top 1%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 11
- Neuroendocrine Tumor Research Advances 11
- Oncology 10
- Lung Cancer Research Studies 8
- Pancreatic and Hepatic Oncology Research 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Martyn Caplin (11 shared papers)Philippe Ruszniewski (11 shared papers)Lucy Wall (10 shared papers)Eva Sedláčková (10 shared papers)Alexandria T. Phan (10 shared papers)Guillaume Cadiot (10 shared papers)Guido Rindi (10 shared papers)Marianne Pavel (10 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Endocrine Related Cancer (1 paper)New England Journal of Medicine (1 paper)BMC Cancer (1 paper)RADAR (Glasgow School of Art) (1 paper)
- Partner nations
- GermanyUnited KingdomFrance
In The Last Decade
Alison Langley
11 papers receiving 1.5k citations
Alison Langley's Hit Papers
Peers
Comparison fields: 5 of 57
- Neurology 732
- Epidemiology 1.4k
- Oncology 864
- Gastroenterology 31
- Endocrinology, Diabetes and Metabolism 71
Countries citing papers authored by Alison Langley
This map shows the geographic impact of Alison Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Langley more than expected).
Fields of papers citing papers by Alison Langley
This network shows the impact of papers produced by Alison Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Langley. The network helps show where Alison Langley may publish in the future.
Co-authors
The 23 scholars most cited alongside Alison Langley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors Hit paper breakdown → | 2014 | 1302 |
| 2 | 2016 | 172 | |
| 3 | 2019 | 49 | |
| 4 | 2014 | 14 | |
| 5 | 2015 | 6 | |
| 6 | 2015 | 4 | |
| 7 | 2015 | 3 | |
| 8 | 2015 | 3 | |
| 9 | 2015 | 3 | |
| 10 | 2015 | 2 | |
| 11 | 2015 | 2 | |
| 12 | Using virtual reality for the training of the Metallographic Replica technique used to inspect power plants by TECNATOM SA | 2011 | 1 |
About Alison Langley
Alison Langley is a scholar working on Epidemiology, Oncology, Neurology, Discrete Mathematics and Combinatorics and Signal Processing, having authored 12 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (8 papers), Neuroblastoma Research and Treatments (8 papers), Pancreatic and Hepatic Oncology Research (3 papers), Time Series Analysis and Forecasting (1 paper), Cancer Treatment and Pharmacology (1 paper) and Modeling, Simulation, and Optimization (1 paper). The work is most often cited by research in Neurology (732 citations), Epidemiology (1.4k citations), Oncology (864 citations), Gastroenterology (31 citations) and Endocrinology, Diabetes and Metabolism (71 citations). Alison Langley has collaborated with scholars based in Germany, United Kingdom and France. Frequent co-authors include Martyn Caplin, Philippe Ruszniewski, Lucy Wall, Eva Sedláčková, Alexandria T. Phan, Guillaume Cadiot, Guido Rindi, Marianne Pavel, Jarosław B. Ćwikła and Edward M. Wolin. Their work appears in journals such as Journal of Clinical Oncology, Endocrine Related Cancer, New England Journal of Medicine, BMC Cancer and RADAR (Glasgow School of Art).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.